These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19383950)

  • 1. Equivalence of generic and brand-name drugs for cardiovascular disease.
    Carter BL
    JAMA; 2009 Apr; 301(16):1654; author reply 1655-6. PubMed ID: 19383950
    [No Abstract]   [Full Text] [Related]  

  • 2. Equivalence of generic and brand-name drugs for cardiovascular disease.
    Zema MJ
    JAMA; 2009 Apr; 301(16):1654-5; author reply 1655-6. PubMed ID: 19383949
    [No Abstract]   [Full Text] [Related]  

  • 3. Equivalence of generic and brand-name drugs for cardiovascular disease.
    Reiffel JA
    JAMA; 2009 Apr; 301(16):1655; author reply 1655-6. PubMed ID: 19383951
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
    Kesselheim AS; Misono AS; Lee JL; Stedman MR; Brookhart MA; Choudhry NK; Shrank WH
    JAMA; 2008 Dec; 300(21):2514-26. PubMed ID: 19050195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology].
    Zapater P; Horga JF
    Rev Neurol; 2000 Jan 16-31; 30(2):146-54. PubMed ID: 10730322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic versus brand-name drugs used in cardiovascular diseases.
    Manzoli L; Flacco ME; Boccia S; D'Andrea E; Panic N; Marzuillo C; Siliquini R; Ricciardi W; Villari P; Ioannidis JP
    Eur J Epidemiol; 2016 Apr; 31(4):351-68. PubMed ID: 26620809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in serum concentrations of and responses to generic verapamil in the elderly.
    Carter BL; Noyes MA; Demmler RW
    Pharmacotherapy; 1993; 13(4):359-68. PubMed ID: 8361862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation substitution: a frequently overlooked variable in cardiovascular drug management.
    Reiffel JA
    Prog Cardiovasc Dis; 2004; 47(1):3-10. PubMed ID: 15517512
    [No Abstract]   [Full Text] [Related]  

  • 9. Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients.
    Saseen JJ; Porter JA; Barnette DJ; Bauman JL; Zajac EJ; Carter BL
    J Clin Pharmacol; 1997 Jun; 37(6):526-34. PubMed ID: 9208360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug.
    Vetchy D; Vetcha M; Rabiskova M; Gryczova E; Bartosikova L
    Medicina (Kaunas); 2007; 43(4):326-31. PubMed ID: 17485960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic substitution--is it safe in patients at high cardiovascular risk?
    Rayner B; Buchanan-Lee B; Brink J; Opie L
    S Afr Med J; 2002 Aug; 92(8):603-4. PubMed ID: 12244616
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 14. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are generic and brand name drugs different in terms of quality?
    Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioequivalence and narrow therapeutic index drugs.
    Benet LZ; Goyan JE
    Pharmacotherapy; 1995; 15(4):433-40. PubMed ID: 7479195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low quality of some generic cardiovascular medicinal products represents a matter for growing concern.
    Tamargo J; Rosano G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):176-187. PubMed ID: 31501855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drugs: Are generics as effective as brand name?
    Vossler DG
    Neurology; 2016 Oct; 87(17):e211-e214. PubMed ID: 27777351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Generic drugs].
    Delporte JP
    Rev Med Liege; 2002 Jan; 57(1):13-22. PubMed ID: 11899492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.